Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous carbetocin vs oxytocin to prevent immediate postpartum hemorrhage after vaginal delivery in high-risk pregnancies
TCTR20160715004Completed
- Sponsor
- Routine to Research Unit, Siriraj Hospital
- Start
- Aug 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, triple-blind trial of carbetocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Routine to Research Unit, Siriraj Hospital. Primary endpoint: Immediate postpartum hemorrhage incidence. Started Aug 2016; status: completed.
02
Drugs
carbetocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on TCTR20160715004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20160715004.